Welcome back to Stockhouse Member Sign In
Sign in with one of the following accounts.
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Use one of the following accounts.
Another day, another bullboard war. But not much else.
Another day, another surprising block of Stockhouse user data.
Newcomers make the list on Stockhouse Research's roundup of what's hot on Stockhouse.com today.
TOUCHE', GV! RIGHT ON AS USUAL. THANKS, jk
Because Crestor/Lititor was not even contemplated and not in the equation at that time...... What was in the equation was the end point...
THANKS GV, MAYBE THAT WILL CLARIFY PRINCE's QUESTIONS. He DOES HAVE A POINT, WITH ALL THE BUCKS SPENT AND EXPERTS RETAINED, WHY HAD NO...
jk: BTW...the post hoc findings re Crestor was found by fluke. Patients that were taking Crestor at the time because of CVD, fared better...
Great news. I spoke with RVX and they are still targeting h1 for the commencement of the trial. I was told to check back end of Feb and...